Market Overview:
The global plasma processing market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing demand for coagulation factor, immune globulin, albumin and other plasma-derived products. In addition, the growing prevalence of chronic diseases and rising number of surgical procedures are also contributing to the growth of this market. The global plasma processing market can be segmented on the basis of type into recovered plasma and source plasma. The recovered plasma segment is further sub-segmented into fresh frozen plasma (FFP), cryoprecipitate and platelet rich Plasma (PRP). The source Plasma segment is further sub-segmented into whole blood donation, automated collection systems and plasmapheresis centers/donor centers. On the basis of application, the global market can be divided into coagulation factor therapy, immune globulin therapy, albumin therapy and others (including erythropoietin [EPO], clotting factors VIII & IX etc.). Coagulation factor therapy held a dominant share in 2017 owing to its high usage in various medical applications such as hemophilia treatment & prevention surgeries etc.
Product Definition:
The term "plasma processing" is used to describe a range of technologies that use plasma – an ionized gas – to modify the surface of materials. Plasma processing can be used to clean, etch, or deposit material on a surface. The importance of plasma processing lies in its ability to modify the surface of materials in a controlled way, which can improve the performance and durability of devices or components.
Recovered Plasma:
Recovered plasma is used in various applications such as protein separation, blood purification and cell isolation. It is also used for the treatment of burn patients. Recovered plasma has been observed to have healing properties and can be applied on wounds with positive results. The product also helps in reducing inflammation along with pain management which makes it a favorable option for sports injuries as well.
Source Plasma:
Plasma is a gaseous form of matter that contains atomic particles and ionized gases. It is generally produced by the controlled heating of gas to high temperature which separates said particles and ions.
Application Insights:
The other applications segment includes protein purification, antibody production and others. Source plasma is used for the preparation of immune globulin (IG), which is a collection of proteins that are specific to the individual¢â‚¬â„¢s own antibodies. These proteins help in protection against infections by binding with antigens present on the surface of bacteria or viruses.
Coagulation factor VIII (CFVIII) is a blood product that helps in treating hemophilia A and B by enabling proper coagulation of blood during its clotting process. It also helps in treating von Willebrand disease, which involves an abnormal absence or deficiency ofvon Willebrand Factor (vWF). The global market for CFVIII was valued at USD 120 million in 2017 due to increasing usage across various applications such as therapeutic use, replacement therapy and gene therapy among others.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of major plasma collection centers in the U.S., such as American Hospital Supply Corp, Baxter Healthcare, and Fresenius Medical Care. In addition, growing demand for plasma-derived products due to increasing incidence of chronic diseases is expected to drive growth over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and rising patient awareness regarding blood donation coupled with a high prevalence of chronic diseases requiring blood transfusion in this region. Moreover, an increase in medical tourism due to affordable treatment options offered by countries like India and China is anticipated bode well for regional market growth during the forecast period from 2018 - 2030 (USD Million).
Europe also accounted for a significant share of revenue generation within this industry on account that most major players operating within it are based there (Germany).
Growth Factors:
- Increasing demand for flat panel displays in consumer electronics and automotive applications
- Rising demand for semiconductor devices used in various end-use applications
- Growing popularity of plasma processing technology over traditional wet etching process
- Proliferation of nanotechnology and MEMS (micro-electromechanical systems) across different industry verticals
- Emergence of new application areas such as flexible displays, OLED lighting, and printed electronics
Scope Of The Report
Report Attributes
Report Details
Report Title
Plasma Processing Market Research Report
By Type
Recovered Plasma, Source Plasma
By Application
Coagulation Factor, Immune Globulin, Albumin, Others
By Companies
Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Plasma Processing Market Report Segments:
The global Plasma Processing market is segmented on the basis of:
Types
Recovered Plasma, Source Plasma
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coagulation Factor, Immune Globulin, Albumin, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
Highlights of The Plasma Processing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Recovered Plasma
- Source Plasma
- By Application:
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Plasma Processing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Plasma processing is a type of industrial chemical process that uses plasma to break down complex molecules into simpler ones. This process can be used to create products such as plastics, pharmaceuticals, and pesticides.
Some of the major players in the plasma processing market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio.
The plasma processing market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Plasma Processing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Plasma Processing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Plasma Processing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Plasma Processing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Plasma Processing Market Size & Forecast, 2018-2028
4.5.1 Plasma Processing Market Size and Y-o-Y Growth
4.5.2 Plasma Processing Market Absolute $ Opportunity
Chapter 5 Global Plasma Processing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Plasma Processing Market Size Forecast by Type
5.2.1 Recovered Plasma
5.2.2 Source Plasma
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Plasma Processing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Plasma Processing Market Size Forecast by Applications
6.2.1 Coagulation Factor
6.2.2 Immune Globulin
6.2.3 Albumin
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Plasma Processing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Plasma Processing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Plasma Processing Analysis and Forecast
9.1 Introduction
9.2 North America Plasma Processing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Plasma Processing Market Size Forecast by Type
9.6.1 Recovered Plasma
9.6.2 Source Plasma
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Plasma Processing Market Size Forecast by Applications
9.10.1 Coagulation Factor
9.10.2 Immune Globulin
9.10.3 Albumin
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Plasma Processing Analysis and Forecast
10.1 Introduction
10.2 Europe Plasma Processing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Plasma Processing Market Size Forecast by Type
10.6.1 Recovered Plasma
10.6.2 Source Plasma
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Plasma Processing Market Size Forecast by Applications
10.10.1 Coagulation Factor
10.10.2 Immune Globulin
10.10.3 Albumin
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Plasma Processing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Plasma Processing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Plasma Processing Market Size Forecast by Type
11.6.1 Recovered Plasma
11.6.2 Source Plasma
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Plasma Processing Market Size Forecast by Applications
11.10.1 Coagulation Factor
11.10.2 Immune Globulin
11.10.3 Albumin
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Plasma Processing Analysis and Forecast
12.1 Introduction
12.2 Latin America Plasma Processing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Plasma Processing Market Size Forecast by Type
12.6.1 Recovered Plasma
12.6.2 Source Plasma
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Plasma Processing Market Size Forecast by Applications
12.10.1 Coagulation Factor
12.10.2 Immune Globulin
12.10.3 Albumin
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Plasma Processing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Plasma Processing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Plasma Processing Market Size Forecast by Type
13.6.1 Recovered Plasma
13.6.2 Source Plasma
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Plasma Processing Market Size Forecast by Applications
13.10.1 Coagulation Factor
13.10.2 Immune Globulin
13.10.3 Albumin
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Plasma Processing Market: Competitive Dashboard
14.2 Global Plasma Processing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Takeda
14.3.2 CSL
14.3.3 Grifols
14.3.4 Octapharma
14.3.5 Kedrion
14.3.6 LFB Group
14.3.7 Biotest
14.3.8 BPL
14.3.9 RAAS
14.3.10 CBPO
14.3.11 Hualan Bio
